Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited - life sciences in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U36999MH2017PTC299383 Incorporated 05 September 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2022
-
Latest filing
EBITDA · FY 2022
Locked
In full report
Net profit · FY 2022
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2025
Balance sheet date

About Regrow Therapeutics Private Limited

Data last updated: 06 March 2026

Regrow Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 05 September 2017, the company has been in operation for over 9 years.

Registered with ROC Mumbai under CIN U36999MH2017PTC299383.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Yash Venilal Sanghavi and Satyen Yeshwant Sanghavi.

Last AGM: 30 October 2025. Financial statements filed for year ended 31 March 2025. Office: 3 Abc Acme Plaza Opp. Sangam Theatres Andheri – Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400059.

The company is associated with 1 brand - Regrow.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website regrow.in.

Company Details of Regrow Therapeutics Private Limited
CIN U36999MH2017PTC299383
Registration Number 299383
Incorporation Date 05 September 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    3 Abc Acme Plaza Opp. Sangam Theatres Andheri – Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400059
  • Industry
    Life Sciences, Biotechnology
Company report
Regrow Therapeutics Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Regrow Therapeutics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Regrow Therapeutics Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited operates one associated brand: Regrow. These brands represent Regrow Therapeutics Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Regrow Biosciences is engaged in regenerative cell therapy solutions. regrow.in

Competitors & Alternatives of Regrow Therapeutics Private Limited

Brands and companies operating in the same space as Regrow Therapeutics Private Limited include Horizon Therapeutics, ZetaGen, Angitia and 7 more.

Competitor Description Location Founded
Horizon Therapeutics Horizon Therapeutics Developer of drugs for treating rare and autoimmune diseases Dublin, Ireland, Ireland 2008
ZetaGen ZetaGen Small molecule therapeutics for bone regeneration are developed. Syracuse, United States, United States 2017
Angitia Angitia Drugs for muscle, bone, and joint diseases are developed. Woodland Hills, United States, United States 2018
Osiris Osiris Stem cell-based regenerative medicines are developed and marketed. Baltimore, United States, United States 1992
Ingeneron Ingeneron Advanced cell separation technologies are developed for regenerative cell preparation. Houston, United States, United States 2005
Enobia Pharma Enobia Pharma Therapies for genetic metabolic bone disorders are developed. Quebec City, Canada, Canada 1997
Osteal Therapeutics Osteal Therapeutics Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections San Clemente, United States, United States 2013
Oscotec Oscotec Korean, clinical-stage, biopharma developing small molecule therapeutics for arthritis and cancer indications Cheonan, South Korea, South Korea 1998
Esprit Pharma Esprit Pharma Develop drugs for genitourinary (GU) disorders East Brunswick, United States, United States 2005
Histogenics Histogenics Restorative cell therapies for orthopedic diseases are developed. Waltham, United States, United States 2000

Business Activity of Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited engages in various business activities. The company's operational segments demonstrate its market presence and business diversification.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Locked Locked Locked Locked
Premium access

Detailed business activity records for Regrow Therapeutics Private Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited is audited by DEEPAKKUMAR A JOSHI & CO for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
DEEPAKKUMAR A JOSHI & CO Locked Locked Locked
Premium access

Complete auditor history for Regrow Therapeutics Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors

Financials of Regrow Therapeutics Private Limited FY 2025 filings available

Premium access

Ten-year financial statements for Regrow Therapeutics Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Regrow Therapeutics Private Limited

Premium access

Shareholding and ownership data for Regrow Therapeutics Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Regrow Therapeutics Private Limited

View historical data on people associated with Regrow Therapeutics Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Regrow Therapeutics Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Regrow Therapeutics Private Limited

Premium access

GST registrations and filing compliance for Regrow Therapeutics Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Regrow Therapeutics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Regrow Therapeutics Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Regrow Therapeutics Private Limited

Premium access

MSME payment history for Regrow Therapeutics Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Regrow Therapeutics Private Limited

Premium access

Corporate group structure for Regrow Therapeutics Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Regrow Therapeutics Private Limited

Premium access

MCA filings and documents for Regrow Therapeutics Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Regrow Therapeutics Private Limited

Activity
30 Oct 2025
Regrow Therapeutics Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records.
Activity
31 Mar 2025
Regrow Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
05 Sep 2017
Yash Venilal Sanghavi was appointed as a Director on 05 Sep 2017 & has been associated with this company since 8 years 10 months.
Directors
05 Sep 2017
Satyen Yeshwant Sanghavi was appointed as a Director on 05 Sep 2017 & has been associated with this company since 8 years 10 months.
Activity
05 Sep 2017
Regrow Therapeutics Private Limited was registered on 05 Sep 2017 with Roc Mumbai I & aged 8 years 10 months as per MCA records.

Recent News on Regrow Therapeutics Private Limited

Frequently Asked Questions about Regrow Therapeutics Private Limited

Regrow Therapeutics Private Limited is an active private limited company in the life sciences sector based in Mumbai, Maharashtra, India. It was incorporated on 05 September 2017 (9+ years old) and is registered under CIN U36999MH2017PTC299383.

The current directors of Regrow Therapeutics Private Limited are:

The primary industry of Regrow Therapeutics Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Regrow Therapeutics Private Limited can be reached at the registered office: 3 Abc Acme Plaza Opp. Sangam Theatres Andheri – Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059, or through the website regrow.in.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

The company has its registered office at 3 Abc Acme Plaza Opp. Sangam Theatres Andheri – Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available